Deerfield Management Company, L.P. (Series C) Synlogic, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.76 Billion
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.59 - $2.51 $604,677 - $954,552	-380,300 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.39 - $3.19 $528,617 - $1.21 Million	380,300 New	380,300 $654,000
Q4 2019 Feb 14, 2020	SELL	$1.96 - $2.81 $2.17 Million - $3.11 Million	-1,107,643 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$5.95 - $14.49 $1.53 Million - $3.73 Million	-257,500 Reduced 18.86%	1,107,643 $7.77 Million
Q1 2018 May 15, 2018	BUY	$9.38 - $12.12 $4.83 Million - $6.24 Million	515,000 Added 60.58%	1,365,143 $12.8 Million
Q3 2017 Nov 13, 2017	BUY	$11.55 - $21.79 $9.82 Million - $18.5 Million	850,143	850,143 $16.2 Million

Others Institutions Holding SYBX

# of Institutions

Shares Held

25.5K

Call Options Held

Put Options Held

View Full List

About SYNLOGIC, INC.

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

More about SYBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account